What's Happening?
A new PCR-based diagnostic platform has been developed by the Aquaculture Pathology Laboratory to evaluate the biosecurity risks associated with formulated aquaculture feeds, particularly those supplemented with shrimp meal. This platform combines two
Polymerase Chain Reaction (PCR) methods: real-time PCR and long-fragment conventional PCR. The issue arises because while real-time PCR can detect pathogen-associated DNA in feeds, it doesn't confirm the presence of a viable, infectious pathogen, as the high temperatures used in aquafeed extrusion can break down pathogen genomes into small, non-infectious fragments. The new approach proposes an initial screening with real-time PCR. If a sample tests positive, it is then subjected to conventional PCR targeting a larger fragment of the pathogen's replicase gene. If the conventional PCR does not yield a positive result, the feed is considered negative for an infectious pathogen, thus posing no biosecurity threat. This method aims to differentiate between the mere presence of pathogen DNA and the actual risk of infection, as demonstrated with White Spot Syndrome Virus (WSSV)-spiked extruded feed.
Why It's Important?
This diagnostic platform is crucial for the U.S. aquaculture industry, particularly shrimp farming, which relies heavily on biosecurity to prevent disease outbreaks. The rapid growth of shrimp aquaculture has been driven by factors including nutritionally complete formulated feeds, but these feeds can inadvertently introduce pathogens. Misinterpreting PCR results, where the detection of non-infectious pathogen DNA leads to unnecessary feed rejections or costly interventions, can have significant economic consequences for producers. By providing a more accurate assessment of infectivity, this new platform can help prevent the spread of diseases like WSSV, which can devastate shrimp populations and lead to substantial financial losses. It allows for more informed decision-making regarding feed safety, ensuring that only truly infectious feeds are identified as biosecurity risks. This precision can safeguard investments in shrimp farming, maintain product quality, and support the sustainability of the aquaculture sector by reducing disease-related mortalities and economic disruptions.
What's Next?
The next steps involve the broader adoption and validation of this combined PCR diagnostic platform within the aquaculture industry. Further research may focus on expanding the platform to detect a wider range of pathogens relevant to shrimp and other aquaculture species. Industry stakeholders, including feed manufacturers, shrimp farmers, and regulatory bodies, will need to collaborate to integrate this new diagnostic approach into standard biosecurity protocols. Training and education will be essential to ensure proper implementation and interpretation of the results. If a feed tests positive by both real-time and conventional PCR assays, further bioassays will be required to definitively determine the potential biosecurity risk and provide final confirmation. The long-term goal is to enhance the reliability of aquafeed screening, thereby strengthening biosecurity measures and contributing to the overall health and economic viability of the aquaculture sector.
Beyond the Headlines
The development of this advanced diagnostic platform highlights a broader scientific challenge in distinguishing between the presence of genetic material and the actual biological threat it poses. This distinction is critical not only in aquaculture but also in other fields like food safety and public health, where PCR-based detection is widely used. The platform's ability to refine risk assessment by focusing on the integrity of pathogen genes rather than just their fragments represents a more sophisticated approach to disease prevention. Ethically, this precision can prevent unnecessary culling of animals or disposal of products based on false positives, reducing waste and economic burden. It also underscores the continuous evolution of diagnostic technologies and the need for ongoing scientific innovation to address complex biological challenges. The success of such platforms can foster greater consumer confidence in aquaculture products by ensuring higher standards of biosecurity and food safety throughout the supply chain.
